Cargando…

Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C

Prostate cancer (PCa) is one of the most common health‐related issues in the male individuals of western countries. Icaritin (ICT) is a traditional Chinese herbal medicine that exhibits antitumor efficacy in variety of cancers including PCa. However, the precise function and detailed molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jimeng, Wu, Xiaobo, Yang, Chen, Rashid, Khalid, Ma, Chenkai, Hu, Mengbo, Ding, Qiang, Jiang, Haowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912031/ https://www.ncbi.nlm.nih.gov/pubmed/31646760 http://dx.doi.org/10.1002/cam4.2630

Ejemplares similares

Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model
por: Wu, Xiaobo, et al.
Publicado: (2020)

Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer
por: Wu, Xiaobo, et al.
Publicado: (2022)

A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020)

miR-484 is associated with disease recurrence and promotes migration in prostate cancer
por: Lee, Daniel, et al.
Publicado: (2020)

Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
por: Zhang, Piqiang, et al.
Publicado: (2020)

Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
por: Stafford, M.Y. Cynthia, et al.
Publicado: (2022)

m(6)A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer
por: Liang, Yingchun, et al.
Publicado: (2022)

Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
por: Xu, Yan, et al.
Publicado: (2013)

Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer
por: Hu, Wei-Wei, et al.
Publicado: (2017)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

Hypoxia‐responsive miR‐124 and miR‐144 reduce hypoxia‐induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
por: Gu, Hao, et al.
Publicado: (2016)

miR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22
por: Lee, Ji-Su, et al.
Publicado: (2019)

miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1
por: Dong, Zhiqiang, et al.
Publicado: (2021)

MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
por: Hu, Xiaobo, et al.
Publicado: (2019)

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1
por: He, Xinxin, et al.
Publicado: (2016)

miR-381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer
por: Qiao, Guanen, et al.
Publicado: (2019)

Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma
por: Li, Yunchao, et al.
Publicado: (2016)

SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381
por: Mi, Hailong, et al.
Publicado: (2020)

Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients
por: Hu, Jimeng, et al.
Publicado: (2015)

TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer
por: Wei, Bingbing, et al.
Publicado: (2017)

Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211
por: Zhang, Hairong, et al.
Publicado: (2021)

LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis
por: Xiao, Shangwen, et al.
Publicado: (2020)

Hsa_circ_0003732 promotes osteosarcoma cells proliferation via miR-545/CCNA2 axis
por: Li, Li, et al.
Publicado: (2020)

miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer
por: Fan, Xiang-da, et al.
Publicado: (2020)

MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1
por: Hu, Weiqun, et al.
Publicado: (2020)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
por: Dou, Dongwei, et al.
Publicado: (2019)

Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway
por: Zhou, Ling, et al.
Publicado: (2021)

miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2
por: Chen, Yougan, et al.
Publicado: (2021)

miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion
por: Ye, Qin, et al.
Publicado: (2021)

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)

miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway
por: Li, Youkong, et al.
Publicado: (2020)

miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells
por: Ming, Jia, et al.
Publicado: (2015)

miR-381 Regulates Neural Stem Cell Proliferation and Differentiation via Regulating Hes1 Expression
por: Shi, Xiaodong, et al.
Publicado: (2015)

Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation
por: Wu, Milu, et al.
Publicado: (2018)

Up-regulation of miR-381 inhibits NAD+ salvage pathway and promotes apoptosis in breast cancer cells
por: Bolandghamat Pour, Zahra, et al.
Publicado: (2019)

miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2
por: Ma, Hai-Feng, et al.
Publicado: (2020)

miR-381-3p Cooperated With Hes1 to Regulate the Proliferation and Differentiation of Retinal Progenitor Cells
por: Wang, Jiajing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dnchpj8es5qsrs6d0kja6tbpdn